PREVENTION BY TIOPRONIN (2-MERCAPTOPROPIONYL GLYCINE) OF METHYLMERCURIC CHLORIDE-INDUCED TERATOGENIC AND FETO-TOXIC EFFECTS IN MICE
PREVENTION BY TIOPRONIN (2-MERCAPTOPROPIONYL GLYCINE) OF METHYLMERCURIC CHLORIDE-INDUCED TERATOGENIC AND FETO-TOXIC EFFECTS IN MICE
复制标题
DOI:
10.1002/tera.1420200213
复制
发表时间:
1979-01-01
期刊:
影响因子:
--
通讯作者:
HIRATA, S
中科院分区:
文献类型:
--
作者:
FUJIMOTO, T;FUYUTA, M;HIRATA, S
Previous investigations (Fuyuta et al., 1976, 1979) showed that a single oral administration of 25 mg/kg methylmercuric chloride (MMC) to pregnant ICR mice on day 10 of pregnancy induced cleft palate in a remarkably high incidence in fetuses. Twenty females in the positive control group were given 25 mg/kg MMC orally on day 10 of pregnancy and then given physiological saline i.p. Twenty females in the negative control group were given distilled H20 orally and then given saline i.p. Cleft palate was found in 98.1% of fetuses in the positive control group and none of them in the negative control group. Twenty females were pretreated with a single oral dose of 25 mg/kg MMC on day 10 of pregnancy and were posttreated with Tiopronin [Tp] i.p., immediately and at every 24, 48 and 72 h after the MMC treatment. The doses of Tp were 320, 160 and 80 mg/kg per day. The incidences of cleft palate in fetuses were reduced to 1.49, 31.3 and 47.8% in the Tp-treated groups with the doses of 320, 160 and 80 mg/kg per day, respectively. Tiopronin could effectively prevent the expected incidence of cleft palate. Other types of abnormalities as well as fetotoxicity represented by reduced fetal body weight were also effectively prevented with the Tp-treatment.